🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested
This retrospective cohort study aims to improve our understanding of the cu...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-06
Trial ID
NCT01064349
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
This study will compare the anti-tumor efficacy of apricoxib and lapatinib/...
Status
Terminated
Location
Arizona Clinical Research Center
Start Date
2008-04
Trial ID
NCT00657137
Treatments Being Tested
This is a Phase II, randomized, open-label, multi-center study evaluating t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01137994
Treatments Being Tested
This is a Phase III, randomized, multicenter, international, 2-arm, open-la...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00829166
Treatments Being Tested
The purpose of this study is to demonstrate that SYD985 \[(vic-)trastuzumab...
Status
Completed
Location
Southern Cancer Center
Start Date
2017-12-15
Trial ID
NCT03262935
Treatments Being Tested
The aim of this study is to evaluate the potential of a Lapatinib plus Cael...
Status
Terminated
Location
Uniklinik Salzburg
Start Date
2009-05
Trial ID
NCT00903656
Treatments Being Tested
This is a prospective, open-label, real-word study evaluating the efficacy ...
Status
Unknown
Location
Xijing Hospital
Start Date
2016-07
Trial ID
NCT03273595
Treatments Being Tested
This is a randomized controlled trial of HER-2 positive breast cancer patie...
Status
Unknown
Location
PUMCH
Start Date
2017-03-01
Trial ID
NCT03085368
Treatments Being Tested